BEIJING (Reuters) -Goldman Sachs said it expects Chinese policymakers to accelerate fiscal easing measures significantly to offset the drag on growth from higher tariffs announced by the United ...

Goldman Sachs analyst Asad Haider assumed coverage of Merck (MRK) with a Buy rating and price target of $103, down from $129. Following the recent selloff, the shares are now trading at levels ...

Goldman Sachs analyst Richard Law initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $30 price target The company’s lead asset, VK2735, is a dual GLP-1/GIP agonist being ...

Languages: English. Goldman Sachs has raised its estimate of a U.S. recession in the next 12 months to 45 percent, citing deteriorating financial conditions and increased policy uncertainty ...

Create a list of the investments you want to track.

Create a list of the investments you want to track.